Clinical Trial Update: Prevention of Irinotecan Induced Diarrhea by Probiotics [Phase 3]

View source ↗

Summary

Phase 3 trial update on using probiotics to prevent irinotecan-induced diarrhea in cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Diarrhea

Snippet

Sponsor: S&D Pharma SK s.r.o. | Conditions: Diarrhea, Cancer | Phase 3 | Status: COMPLETED